Abbott's strong innovation pipeline, including advancements in CGM systems, supports its market share gains and growth ...

The fragility of the infant formula market is being tested again — this time by legal fights over safety labeling. The big ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...

Adam Maeder, an analyst from Piper Sandler, has initiated a new Buy rating on Abbott Laboratories (ABT). Adam Maeder has given his Buy rating ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

The conventional wisdom is that there are two important aspects of timing in investing: when to buy a stock and when to sell ...

Abbott (ABT) closed the most recent trading day at $113.70, moving -0.39% from the previous trading session. Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage ...

Your donation makes it possible for us to keep doing this important work, keeping you informed every step of the way to the November election Ms Abbott ... they tried to ensure that we failed ...

The 10-year plan includes projects aimed at improving safety, mobility, maintenance and more ...

Stan Lambert received an endorsement from Texas Governor Greg Abbott on September 20, just seven weeks before Election Day.